Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Methods in Molecular Medicine
|
November 7, 2007
Analysis of Th1/Th2 T-cell subsets
Alla Skapenko, Hendrik Schulze-Koops
Nature Reviews. Rheumatology
|
December 14, 2022
COVID-19 vaccination in individuals with inflammatory rheumatic diseases
Alla Skapenko, Hendrik Schulze-Koops
Rheumatology (Oxford, England)
|
September 15, 2017
Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm
Hendrik Schulze-Koops, Alla Skapenko
Expert Opinion on Biological Therapy
|
October 22, 2002
Immunosuppression with biologicals: prospects for the treatment of autoimmune diseases
Hendrik Schulze-Koops, Alla Skapenko
Nature Reviews. Rheumatology
|
November 2, 2010
Inflammation: TREG cell control of autoimmune inflammation: a matter of timing?
Hendrik Schulze-Koops, Alla Skapenko
RMD Open
|
September 12, 2022
Reactive arthritis after SARS-CoV-2 infection
Sophia Dombret, Alla Skapenko, Hendrik Schulze-Koops
Nature Reviews. Rheumatology
|
July 29, 2009
Prognostic factors in rheumatoid arthritis in the era of biologic agents
Alla Skapenko, Iryna Prots, Hendrik Schulze-Koops
RMD Open
|
February 25, 2021
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
Hendrik Schulze-Koops, Christof Specker, Alla Skapenko
Human Immunology
|
August 18, 2009
Homotypic T-cell/T-cell interaction induces T-cell activation, proliferation, and differentiation
Andreas Ramming, Katja Thümmler, Hendrik Schulze-Koops, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 13, 2019
A Rare Side Effect of Checkpoint Inhibitor Therapy-Nivolumab-Induced Axial Polyarthritis of the Facet and Costovertebral Joints
Jonas Feist, Antoine Murray, Alla Skapenko, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Methods in Molecular Medicine
|
November 7, 2007
Analysis of Th1/Th2 T-cell subsets
Alla Skapenko, Hendrik Schulze-Koops
Nature Reviews. Rheumatology
|
December 14, 2022
COVID-19 vaccination in individuals with inflammatory rheumatic diseases
Alla Skapenko, Hendrik Schulze-Koops
Rheumatology (Oxford, England)
|
September 15, 2017
Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm
Hendrik Schulze-Koops, Alla Skapenko
Expert Opinion on Biological Therapy
|
October 22, 2002
Immunosuppression with biologicals: prospects for the treatment of autoimmune diseases
Hendrik Schulze-Koops, Alla Skapenko
Nature Reviews. Rheumatology
|
November 2, 2010
Inflammation: TREG cell control of autoimmune inflammation: a matter of timing?
Hendrik Schulze-Koops, Alla Skapenko
RMD Open
|
September 12, 2022
Reactive arthritis after SARS-CoV-2 infection
Sophia Dombret, Alla Skapenko, Hendrik Schulze-Koops
Nature Reviews. Rheumatology
|
July 29, 2009
Prognostic factors in rheumatoid arthritis in the era of biologic agents
Alla Skapenko, Iryna Prots, Hendrik Schulze-Koops
RMD Open
|
February 25, 2021
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
Hendrik Schulze-Koops, Christof Specker, Alla Skapenko
Human Immunology
|
August 18, 2009
Homotypic T-cell/T-cell interaction induces T-cell activation, proliferation, and differentiation
Andreas Ramming, Katja Thümmler, Hendrik Schulze-Koops, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 13, 2019
A Rare Side Effect of Checkpoint Inhibitor Therapy-Nivolumab-Induced Axial Polyarthritis of the Facet and Costovertebral Joints
Jonas Feist, Antoine Murray, Alla Skapenko, et al.
Page
of 6